Sonic Incytes_Secondary_Colour.jpg
Sonic Incytes Medical Corp. Successfully Completes Series A Raise of US$7.3M to Accelerate Velacur™ Commercialization
December 07, 2021 10:00 ET | Sonic Incytes Medical Corp.
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M...
ProgenityLogo.jpg
Progenity Announces New Patent for Single-Molecule Detection Technology
December 02, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a...
Rome Foundation Releases Clinical Criteria to Better Meet Needs of Patients
November 29, 2021 09:00 ET | Rome Foundation
RALEIGH, N.C., Nov. 29, 2021 (GLOBE NEWSWIRE) -- The Rome Foundation has published a groundbreaking modification of the Rome IV diagnostic criteria of the Disorders of Gut Brain Interaction (DGBI -...
ProgenityLogo.jpg
Progenity Strengthens its Liquidity Position
November 23, 2021 06:30 ET | Progenity, Inc.
Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN...
ProgenityLogo.jpg
Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 15, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at...
Sonic Incytes_Secondary_Colour.jpg
Velacur™ Data Presented at 2021 AASLD The Liver Meeting®
November 12, 2021 08:00 ET | Sonic Incytes Medical Corp.
VANCOUVER, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of VelacurTM – the first handheld 3D liver health...
ProgenityLogo.jpg
Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 10, 2021 16:01 ET | Progenity, Inc.
Added important patents further protecting the company’s therapeutic delivery technologiesAdded strong biotherapeutics capabilities to management team and board of directorsImplemented cost-cutting...
ProgenityLogo.jpg
Progenity Appoints Adi Mohanty as Chief Executive Officer
November 09, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the...
ProgenityLogo.jpg
Progenity Announces Appointment of Jill Howe to its Board of Directors
November 04, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November...
ProgenityLogo.jpg
Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update
November 03, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report third quarter 2021 financial results on...